There is debate surrounding the use of PCSK9 inhibitors among patients who are intolerant to statins. What is your opinion? Let us know by taking our poll.
Approximately 100,000 individuals in the United States are affected by idiopathic pulmonary fibrosis. Should these patients all receive anti-fibrotic therapy? Share your thoughts by taking this poll.
Patients often experience barriers to health care for one reason or another. What experiences have you and your patients had with barriers to migraine care?